$348.18
0.94%
NYSE, Jan 02, 10:11 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$348.18
-18.50 5.05% 1M
-43.63 11.14% 6M
-3.29 0.94% YTD
-10.54 2.94% 1Y
+103.69 42.41% 3Y
+109.16 45.67% 5Y
+258.16 286.78% 10Y
+303.84 685.25% 20Y
NYSE, Closing price Fri, Jan 02 2026
-3.29 0.94%

New AI Insights on Stryker Insights AI Insights on Stryker

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$133.2b
Enterprise Value
$144.7b
Net debt
$11.5b
Cash
$3.3b
Shares outstanding
382.3m
Valuation (TTM | estimate)
P/E
45.8 | 25.4
P/S
5.5 | 5.3
EV/Sales
5.9 | 5.7
EV/FCF
35.5
P/B
6.1
Dividends
DPS
$3.40
Yield 1Y | 5Y
1.0% | 1.0%
Growth 1Y | 5Y
4.9% | 7.6%
Payout 1Y | 3Y
41.8% | 41.1%
Increased
16 Years
Financials (TTM | estimate)
Revenue
$24.4b | $25.3b
EBITDA
$6.1b | $7.2b
EBIT
$5.4b | $6.4b
Net Income
$2.9b | $5.2b
Free Cash Flow
$4.1b
Growth (TTM | estimate)
Revenue
11.0% | 12.0%
EBITDA
11.7% | 27.2%
EBIT
11.5% | 27.7%
Net Income
-18.0% | 74.9%
Free Cash Flow
27.1%
Margin (TTM | estimate)
Gross
64.6%
EBITDA
25.0% | 28.5%
EBIT
22.1%
Net
12.1% | 20.7%
Free Cash Flow
16.7%
Financial Health
Equity Ratio
48.0%
Return on Equity
14.5%
ROCE
13.6%
ROIC
-
Debt/Equity
0.7
More
EPS
$7.6
FCF per Share
$10.7
Short interest
1.2%
Employees
53k
Rev per Employee
$430.0k
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

36 Analysts have issued a Stryker forecast:

26x Buy
72%
10x Hold
28%

Analyst Opinions

36 Analysts have issued a Stryker forecast:

Buy
72%
Hold
28%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
24,381 24,381
11% 11%
100%
- Direct Costs 8,633 8,633
9% 9%
35%
15,748 15,748
12% 12%
65%
- Selling and Administrative Expenses 8,121 8,121
13% 13%
33%
- Research and Development Expense 1,529 1,529
9% 9%
6%
6,098 6,098
12% 12%
25%
- Depreciation and Amortization 699 699
13% 13%
3%
EBIT (Operating Income) EBIT 5,399 5,399
12% 12%
22%
Net Profit 2,943 2,943
18% 18%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
Seeking Alpha
8 days ago
Chevron (CVX) is expected to extend its dividend growth streak to 39 years, but with a muted 3–4% increase amid lower oil prices. CVX's earnings remain under pressure from declining oil prices despite cost-saving initiatives and the Hess acquisition, leading to subdued dividend growth. Dividend increases in January will generally be modest, with select companies like Fastenal, S&P Global, and C...
Positive
MarketBeat
18 days ago
Major players in healthcare are increasing their commitments to return capital to shareholders, resulting in significantly higher dividends. Recent dividend announcements from major companies in the sector highlight evolving capital return strategies.
Neutral
GlobeNewsWire
24 days ago
Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  “We remain confident in our ability to deliver strong fin...
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 53,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today